Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$107.56 n/a | n/a%
08/29/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 107.56
52 Week High 108.77
52 Week Low 58.81
Avg. Daily Vol. (Mil) 11.99
Beta (3 year) 0.94
Share Related Items
Mkt Cap (Mil) 162,595.27
Shares Out (Mil) 1,511.67
Float (Mil) 1,529.66
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.00
Current Ratio 2.50
LT Debt/ Equity 0.49
Total Debt / Equity 0.59
Valuation Ratios
Price Earnings 24.20
Price/Sales 9.32
Price/Book 10.10
Price/Cash Flow 19.90
Per Share Data
Earnings 4.45
Sales 11.53
Book Value 10.64
Cash Flow 5.39
Business Summary
Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.
General Information
333 Lakeside Drive
Foster City, CA 94404
www.gilead.com
Industry : Drugs
Sector: Health Care
Employees: 6100
CEO: Dr. John C. Martin,M.D.
Short Interest
Current Month (Mil) 90.07
Previous Month (Mil) 98.47
Short Interest Ratio (Days) 6.80
Management Effectiveness
Return on Equity 46.30
Return on Assets 23.90
Return on Investments 31.00
Profitability
Gross Margin 85.20
EBIT Margin 56.10
Profit Margin 42.70

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter